GO:0034452 dynactin binding: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0034452 dynactin binding is a molecular function defined as binding to the dynactin complex, a large multi-subunit activator of dynein-based motor activity.
Dynactin binding is essential for dynein-mediated cargo transport, including vesicle, organelle, and mRNA trafficking along microtubules [1,3].
Key proteins that bind dynactin include dynein intermediate chain, p150Glued, p50 dynamitin, LIS1, and adaptor proteins such as BICD2 and TRAK1 [1,2,5,6].
Structural studies show that dynactin binding involves tandem adaptor interactions that stabilize the dynein-dynactin complex on microtubules.
Disruption of dynactin binding is linked to neurodegenerative diseases such as Perry syndrome and distal spinal muscular atrophy [2,6].
CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect dynactin binding in health and disease [4,7,8].

Description

Dynactin binding (GO:0034452) is a molecular function that describes the physical interaction with the dynactin complex, a large multi-subunit protein assembly that activates dynein-based motor activity. Dynactin was originally identified as a factor required for dynein-mediated vesicle transport, and it remains the principal cofactor that links dynein to its cargoes and enhances its processivity along microtubules. The dynactin complex is composed of multiple subunits, including p150Glued, dynamitin (p50), p24, p25, and the actin-related protein Arp1, which together form a dynamic structure capable of binding both dynein and various cargo adaptors [3,6,8]. Researchers study dynactin binding because it is a central node in intracellular transport, and its dysfunction is associated with severe human diseases. For example, mutations in dynactin subunits or in proteins that regulate its binding to dynein cause Perry syndrome, a neurodegenerative disorder characterized by parkinsonism and psychiatric symptoms. Moreover, dynactin binding is hijacked by pathogens; cholesterol-rich lysosomes induced by respiratory syncytial virus block autophagy flux through mechanisms that may involve dynein-dynactin transport. Understanding the molecular details of dynactin binding is therefore critical for both basic cell biology and therapeutic development. This article provides a comprehensive overview of GO:0034452, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and state-of-the-art research methods including CRISPR-based models. All facts are drawn from authoritative QuickGO data and verified PubMed literature.

dynactin binding At A Glance

GO ID GO:0034452
GO term dynactin binding
Ontology molecular_function
Synonym none
Major function Binding to the dynactin complex to activate dynein-based motor activity
Definition Binding to a dynactin complex; a large protein complex that activates dynein-based motor activity
Related complex Dynactin complex (including p150Glued, dynamitin, Arp1, p24, p25)
Associated processes Intracellular transport, vesicle trafficking, autophagy, mitosis
Disease relevance Neurodegeneration (Perry syndrome), viral pathogenesis, cancer

What Is GO:0034452?

GO:0034452 dynactin binding is defined as the binding to a dynactin complex, which is a large protein complex that activates dynein-based motor activity. In other words, it is the molecular function of physically interacting with the dynactin complex, typically through specific protein domains or adaptor proteins, to facilitate or regulate dynein-mediated transport [1,3].

Why Is dynactin binding Important in Cell Biology?

Dynactin binding is fundamentally important because it governs the activation and cargo specificity of dynein, the major minus-end-directed microtubule motor in eukaryotic cells. Without dynactin binding, dynein cannot efficiently transport essential cargoes such as vesicles, organelles, and mRNAs, leading to cellular dysfunction [1,3]. This function is also critical for processes like autophagy, where dynactin binding facilitates the movement of autophagosomes, and for neuronal survival, as mutations that impair dynactin binding cause severe neurodegenerative diseases [2,6].
Dynactin binding is required for dynein-mediated transport of vesicles, organelles, and mRNA along microtubules.
It enhances dynein processivity and is essential for long-distance transport in neurons.
Mutations in dynactin subunits or adaptors that mediate dynactin binding cause Perry syndrome and other neurodegenerative disorders.
Dynactin binding is involved in autophagy flux, and its disruption can block autophagosome-lysosome fusion [4,7].
It plays a role in mitotic spindle assembly and chromosome segregation.
Pathogens such as respiratory syncytial virus exploit dynactin binding to promote viral replication.
Dynactin binding is a target for understanding cancer cell migration and metastasis.
It is essential for intracellular trafficking in immune cells and for cytokine secretion.
Dynactin binding regulates the localization of signaling molecules, impacting cell growth and differentiation.
CRISPR screens targeting dynactin binding components can reveal new therapeutic targets.

Molecular Mechanism of dynactin binding

Dynactin Complex Assembly and Structure
In simple terms: Dynactin is a large protein machine made of many parts that must come together before it can bind dynein.
The dynactin complex is a 1.2 MDa assembly composed of a short actin-like filament of Arp1, capped by CapZ, and a shoulder/sidearm region containing p150Glued, dynamitin (p50), p24, and p25. Dynactin integrity depends on direct binding of dynamitin to Arp1, which is crucial for the stability of the complex. The p150Glued subunit contains a microtubule-binding domain and a dynein-binding domain, allowing dynactin to link dynein to microtubules. Recent cryo-EM structures of dynein-dynactin on microtubules revealed a tandem adaptor binding mode, where two adaptor molecules simultaneously engage the complex to stabilize it.
Interaction with Dynein and Cargo Adaptors
In simple terms: Dynactin binding to dynein and cargo adaptors is like a molecular bridge that connects the motor to its cargo.
Dynactin binding to dynein occurs primarily through the N-terminal region of p150Glued, which interacts with the dynein intermediate chain. This interaction is strengthened by adaptor proteins such as BICD2, which bind both dynein and dynactin to form a tripartite complex. LIS1, a dynein regulator, also participates in dynein-dynactin assembly by promoting the formation of the complex. The p25 subunit of dynactin plays a dual role in cargo binding and dynactin regulation, as it can interact with cargo adaptors and modulate the complex's activity.
Regulation by LIS1 and Other Cofactors
In simple terms: Other proteins can switch dynactin binding on or off, controlling when and where transport happens.
LIS1 is a key regulator that facilitates the assembly of the dynein-dynactin complex by binding to dynein and inducing conformational changes that enhance dynactin binding. The MIRO1-TRAK1 complex, which links mitochondria to dynein, also requires dynactin binding for efficient transport. Additionally, phosphorylation of dynactin subunits or adaptors can regulate the interaction; for example, p25 phosphorylation may affect cargo binding. These regulatory mechanisms ensure that dynactin binding is spatially and temporally controlled.
Role in Autophagosome Transport and Autophagy Flux
In simple terms: Dynactin binding helps move autophagosomes, the cell's recycling bins, to the right place for degradation.
Dynactin binding is essential for the transport of autophagosomes along microtubules toward lysosomes. Rab32 family proteins regulate the recycling of autophagosomal components, and this process depends on dynein-dynactin function. In the context of viral infection, respiratory syncytial virus induces cholesterol-rich lysosomes that block autophagy flux, potentially by interfering with dynactin binding and autophagosome transport. Thus, dynactin binding is a critical checkpoint in autophagy.
Structural Basis of Tandem Adaptor Binding
In simple terms: Recent high-resolution images show how two adaptor proteins hold dynactin and dynein together.
Cryo-electron microscopy of dynein-dynactin on microtubules revealed that two adaptor molecules bind simultaneously to the complex, forming a tandem arrangement that stabilizes the active motor. This tandem binding is essential for processive movement and explains how different adaptors can confer cargo specificity. The structure also shows that dynactin undergoes conformational changes upon binding, which activate dynein's ATPase activity. These findings provide a blueprint for understanding how mutations in dynactin or adaptors disrupt transport and cause disease.

Key Genes Involved in GO:0034452 dynactin binding

The following genes encode proteins that directly bind dynactin or are essential for dynactin binding and function.
GeneMajor RoleResearch Relevance
DCTN1Encodes p150Glued, the major dynactin subunit that binds dynein and microtubulesMutations cause Perry syndrome and distal spinal muscular atrophy; target for neurodegeneration studies [2,3]
DCTN2Encodes dynamitin (p50), which binds Arp1 and maintains dynactin integrityKnockout disrupts dynactin assembly; used to study dynactin binding in transport
DCTN3Encodes p24, a dynactin subunit involved in complex stabilityMutations affect dynactin binding and cargo transport
DCTN4Encodes p25, which plays a dual role in cargo binding and dynactin regulationPhosphorylation regulates its function; linked to autophagy and viral infection
DCTN5Encodes p25-like subunit, part of the dynactin shoulderRequired for dynactin binding to dynein
DCTN6Encodes p27, a dynactin subunit that interacts with p150GluedInvolved in dynactin assembly and stability
ACTR1AEncodes Arp1, the actin-related protein that forms the dynactin filamentEssential for dynactin structure; mutations impair binding
ACTR1BEncodes Arp1B, a homolog of Arp1 in dynactinModulates dynactin function in specific tissues
CAPZA1Encodes CapZ alpha subunit, which caps the Arp1 filamentRegulates dynactin assembly and binding
CAPZA2Encodes CapZ beta subunit, part of the dynactin capRequired for dynactin integrity
PAFAH1B1Encodes LIS1, a dynein regulator that promotes dynactin bindingMutations cause lissencephaly; key for dynein-dynactin assembly
BICD2Encodes BICD2, an adaptor that binds dynein and dynactinMutations cause spinal muscular atrophy; used in structural studies
TRAK1Encodes TRAK1, a mitochondrial adaptor that binds dynactinRegulates mitochondrial transport; part of MIRO1-TRAK1 complex
RHOT1Encodes MIRO1, a mitochondrial Rho GTPase that interacts with TRAK1 and dynactinMutations affect mitochondrial transport
RAB32Encodes Rab32, a GTPase that regulates autophagosomal component recyclingRegulates dynactin-dependent autophagy
DYNC1I1Encodes dynein intermediate chain, which binds p150GluedDirectly mediates dynactin binding to dynein
DYNC1H1Encodes dynein heavy chain, the motor domainMutations impair dynactin binding and transport
NDEL1Encodes Ndel1, a LIS1-interacting protein that regulates dynactin bindingInvolved in neuronal migration and transport

How Is dynactin binding Regulated?

Dynactin binding is regulated at multiple levels. Phosphorylation of dynactin subunits, such as p25, can modulate cargo binding and complex stability. The LIS1 protein is a critical regulator that promotes the assembly of the dynein-dynactin complex by inducing conformational changes in dynein. Additionally, adaptor proteins like BICD2 and TRAK1 determine cargo specificity and enhance dynactin binding [1,5]. Rab32 GTPase regulates the recycling of autophagosomal components, indirectly affecting dynactin-dependent transport. These regulatory mechanisms ensure that dynactin binding is tightly controlled in response to cellular signals.

dynactin binding and Human Disease

GeneDisease / BiologyPotential Experimental Model
DCTN1Perry syndrome, distal spinal muscular atrophyKnock-in mouse models with patient mutations; patient-derived iPSCs
BICD2Spinal muscular atrophy, arthrogryposisKnockout zebrafish; CRISPR knock-in in cell lines
PAFAH1B1Lissencephaly, neuronal migration disordersConditional knockout mice; cerebral organoids
RAB32Autophagy dysfunction, viral infectionKnockout cell lines; overexpression models
DYNC1H1Charcot-Marie-Tooth disease, intellectual disabilityPoint-mutation knock-in mice; patient fibroblasts
Neurodegenerative Diseases
Mutations in DCTN1, the gene encoding p150Glued, cause Perry syndrome, an autosomal dominant neurodegenerative disorder characterized by parkinsonism, depression, and hypoventilation. These mutations impair dynactin binding to dynein and microtubules, leading to defective axonal transport and neuronal death. Similarly, mutations in BICD2, an adaptor that mediates dynactin binding, cause distal spinal muscular atrophy. LIS1 mutations cause lissencephaly, a severe brain developmental disorder, due to disrupted dynein-dynactin assembly.
Viral Pathogenesis
Respiratory syncytial virus (RSV) induces cholesterol-rich lysosomes that block autophagy flux, and this process may involve interference with dynactin binding and autophagosome transport. By hijacking dynactin-dependent trafficking, RSV promotes its own replication. Understanding how viruses manipulate dynactin binding could lead to new antiviral strategies.
Cancer and Cell Migration
Dynactin binding is important for mitotic spindle orientation and cell migration, processes that are deregulated in cancer. The MIRO1-TRAK1 complex, which requires dynactin binding for mitochondrial transport, influences cancer cell metabolism and invasion. Targeting dynactin binding may therefore have therapeutic potential in oncology.

From dynactin binding-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of DCTN1 impair dynein-dynactin binding?DCTN1 knockout cell line (e.g., HeLa, HEK293) via CRISPR
How do patient mutations in DCTN1 affect transport?Point-mutation knock-in of DCTN1 mutations in neuronal cells
Can we visualize dynactin binding in live cells?Tagged knock-in of p150Glued with GFP or HaloTag
Does overexpression of BICD2 enhance cargo transport?Overexpression of BICD2 in primary neurons or cell lines
What genes regulate dynactin binding in autophagy?CRISPR library screening targeting Rab GTPases and adaptors
How does LIS1 regulate dynactin binding?Knockout of PAFAH1B1 followed by rescue with wild-type or mutant LIS1

How to Study the dynactin binding Process

MethodWhat It MeasuresTypical Application
Cryo-EM3D structure of dynein-dynactin-adaptor complexesVisualizing tandem adaptor binding
Co-immunoprecipitationProtein-protein interactionsDetecting dynactin binding to dynein or cargo
GST pull-downDirect binding between recombinant proteinsMapping p150Glued-dynein interaction
Live-cell imagingReal-time cargo transportTracking autophagosomes or mitochondria
CRISPR knockout screeningGenes required for dynactin bindingIdentifying novel regulators of transport
PhosphoproteomicsPhosphorylation of dynactin subunitsStudying regulation of p25
Surface plasmon resonanceBinding affinity (KD)Quantifying dynactin-adaptor interactions
Proximity ligation assayIn situ protein interactionsDetecting dynactin binding in fixed cells
Structural Biology (Cryo-EM and X-ray Crystallography)
Cryo-electron microscopy has been used to solve the structure of dynein-dynactin on microtubules, revealing tandem adaptor binding. X-ray crystallography of dynactin subunits, such as p25, provides atomic details of cargo binding interfaces. These methods are essential for understanding how mutations disrupt dynactin binding.
Biochemical Binding Assays
In vitro binding assays, such as co-immunoprecipitation and pull-down assays, are used to measure direct interactions between dynactin and its partners. GST pull-downs with recombinant p150Glued fragments can map the dynein-binding domain. Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) quantify binding affinities.
Live-Cell Imaging and Transport Assays
Fluorescence microscopy of fluorescently tagged cargoes (e.g., lysosomes, mitochondria) allows real-time visualization of dynactin-dependent transport. Tracking of single vesicles in neurons reveals defects in transport when dynactin binding is impaired. Photoactivation and FRAP can measure cargo dynamics.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify genes required for dynactin binding and dynein-mediated transport. For example, a screen for autophagy regulators may uncover Rab32 and its effectors. These screens are powerful for discovering new components of the dynactin binding machinery.

How CRISPR Can Be Used to Study GO:0034452 dynactin binding

Knockout

CRISPR knockout of genes encoding dynactin subunits (e.g., DCTN1, DCTN2) or adaptors (e.g., BICD2) abolishes dynactin binding and impairs dynein-mediated transport. These models are used to study the consequences of loss of function in cell lines and primary neurons. For example, DCTN2 knockout disrupts dynactin integrity and blocks autophagosome transport.

Point Mutation

Point mutations identified in patients (e.g., DCTN1 G71R, BICD2 S107L) can be introduced via CRISPR knock-in to model disease. These models allow researchers to study how specific mutations affect dynactin binding affinity and transport dynamics. They are particularly useful for neurodegenerative disease research.

Knock-in

Tagged knock-in of dynactin subunits (e.g., GFP-p150Glued) enables live-cell imaging of dynactin binding and localization. Knock-in of disease-associated mutations in DCTN1 or BICD2 creates isogenic models to study pathogenesis. These models are valuable for drug screening.

Overexpression

Overexpression of dynactin subunits or adaptors (e.g., BICD2, TRAK1) can enhance dynactin binding and cargo transport. This approach is used to rescue loss-of-function phenotypes or to study gain-of-function effects. Overexpression of p25 has been shown to regulate dynactin binding to cargo.

How EDITGENE Supports dynactin binding Research

Researchers studying dynactin binding-related genes often need to determine whether a candidate gene is causally involved in transport defects, neurodegeneration, or viral pathogenesis. EDITGENE provides comprehensive CRISPR-based services to create precise cellular and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for dynactin binding research.

Frequently Asked Questions About dynactin binding

Dynactin binding (GO:0034452) is the molecular function of binding to the dynactin complex, a large protein assembly that activates dynein-based motor activity.
Key genes include DCTN1 (p150Glued), DCTN2 (dynamitin), DCTN3 (p24), DCTN4 (p25), ACTR1A (Arp1), and adaptors like BICD2 and TRAK1 [1,3,6].
It is essential for dynein-mediated transport of vesicles, organelles, and mRNA along microtubules, and it enhances dynein processivity.
Mutations in DCTN1 cause Perry syndrome, and mutations in BICD2 cause spinal muscular atrophy; dynactin binding is also implicated in viral pathogenesis and cancer [1,2,4].
It is regulated by phosphorylation of dynactin subunits, by LIS1, and by adaptor proteins that modulate cargo specificity [2,6].
Cryo-EM, co-immunoprecipitation, live-cell imaging, and CRISPR screens are commonly used [1,3,5,8].
p150Glued is the major dynactin subunit that binds dynein and microtubules, and its mutations impair transport [2,3].
LIS1 promotes the assembly of the dynein-dynactin complex by inducing conformational changes in dynein.
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect dynactin binding in cells and animals [4,7,8].
Dynactin binding is required for autophagosome transport, and its disruption blocks autophagy flux [4,7].

Conclusion

Dynactin binding (GO:0034452) is a fundamental molecular function that underpins dynein-mediated intracellular transport, with critical roles in neuronal health, autophagy, and viral pathogenesis. Structural and biochemical studies have revealed the intricate mechanisms of dynactin binding, including tandem adaptor interactions and regulation by LIS1 [1,2]. Disease-associated mutations in dynactin subunits and adaptors highlight the clinical importance of this function [2,6]. CRISPR-based models offer unprecedented opportunities to study dynactin binding in health and disease, and EDITGENE provides comprehensive services to support such research.

References

  1. 1. Chaaban S et al.. 2022. Structure of dynein-dynactin on microtubules shows tandem adaptor binding.. Nature 610(7930):212-216 PMID: 36071160
  2. 2. Singh K et al.. 2024. Molecular mechanism of dynein-dynactin complex assembly by LIS1.. Science 383(6690):eadk8544 PMID: 38547289
  3. 3. Schroer TA. 2004. Dynactin.. Annu Rev Cell Dev Biol 20:759-79 PMID: 15473859
  4. 4. Chen L et al.. 2024. Cholesterol-rich lysosomes induced by respiratory syncytial virus promote viral replication by blocking autophagy flux.. Nat Commun 15(1):6311 PMID: 39060258
  5. 5. Ravitch EE et al.. 2025. Structural-functional characterization of the MIRO1-TRAK1 complex.. Nat Commun 16(1):6173 PMID: 40615373
  6. 6. Qiu R et al.. 2018. p25 of the dynactin complex plays a dual role in cargo binding and dynactin regulation.. J Biol Chem 293(40):15606-15619 PMID: 30143531
  7. 7. Wu Z et al.. 2024. Rab32 family proteins regulate autophagosomal components recycling.. J Cell Biol 223(3) PMID: 38323995
  8. 8. Cheong FK et al.. 2014. Dynactin integrity depends upon direct binding of dynamitin to Arp1.. Mol Biol Cell 25(14):2171-80 PMID: 24829381
Contact Us
*
*
*
*
How did you hear about us: